Letter of response to “Myotonic dystrophy type 1, individualised respiratory care rather than standart prognostication”

  • Salvatore Rossi
    Affiliations
    Department of Neurology, Fondazione Policlinico Universitario A. Gemelli IRCSS, Largo A. Gemelli 8, 00168, Rome

    Institute of Neurology, Catholic University of the Sacred Heart, Largo F. Vito 1, 00168, Rome
    Search for articles by this author
  • Gabriella Silvestri
    Correspondence
    Corresponding author.
    Affiliations
    Department of Neurology, Fondazione Policlinico Universitario A. Gemelli IRCSS, Largo A. Gemelli 8, 00168, Rome

    Institute of Neurology, Catholic University of the Sacred Heart, Largo F. Vito 1, 00168, Rome
    Search for articles by this author
Published:April 19, 2019DOI:https://doi.org/10.1016/j.jns.2019.04.021
      We read with interest the letter “Myotonic Dystrophy type 1, Individualized Respiratory Care Rather Than Standard Prognostication” by Dr. Yetimakman and colleagues [
      • Yetimakman A.F.
      • Bayrakçı B.
      • Esquinas A.M.
      Myotonic Dystrophy Type 1, Individualised Respiratory Care Rather Than Standard Prognostication.
      ] refering to our paper recently published on your Journal [
      • Rossi S.
      • Della Marca G.
      • Ricci M.
      • Perna A.
      • Nicoletti T.F.
      • Brunetti V.
      • Meleo E.
      • Calvello M.
      • Petrucci A.
      • Antonini G.
      • Bucci E.
      • Licchelli L.
      • Sancricca C.
      • Massa R.
      • Rastelli E.
      • Botta A.
      • Di Muzio A.
      • Romano S.
      • Garibaldi M.
      • Silvestri G.
      Prevalence and predictor factors of respiratory impairment in a large cohort of patients with Myotonic Dystrophy type 1 (DM1): a retrospective, cross sectional study.
      ] and carefully revised the comments and issues raised in this letter.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal

      Subscribe:

      Subscribe to Journal of the Neurological Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Yetimakman A.F.
        • Bayrakçı B.
        • Esquinas A.M.
        Myotonic Dystrophy Type 1, Individualised Respiratory Care Rather Than Standard Prognostication.
        J. Neurol. Sci. 2019; (in press)
        • Rossi S.
        • Della Marca G.
        • Ricci M.
        • Perna A.
        • Nicoletti T.F.
        • Brunetti V.
        • Meleo E.
        • Calvello M.
        • Petrucci A.
        • Antonini G.
        • Bucci E.
        • Licchelli L.
        • Sancricca C.
        • Massa R.
        • Rastelli E.
        • Botta A.
        • Di Muzio A.
        • Romano S.
        • Garibaldi M.
        • Silvestri G.
        Prevalence and predictor factors of respiratory impairment in a large cohort of patients with Myotonic Dystrophy type 1 (DM1): a retrospective, cross sectional study.
        J. Neurol. Sci. 2019; 399: 118-124
        • Sansone V.A.
        • Gagnon C.
        Participants of the 207th ENMC workshop, 207th ENMC workshop on chronic respiratory insufficiency in myotonic dystrophies: management and implications for research, 27–29 June 2014, Naarden, the Netherlands.
        Neuromuscul. Disord. 2015; 25: 432-442https://doi.org/10.1016/j.nmd.2015
        • O'Donoghue F.J.
        • Borel J.C.
        • Dauvilliers Y.
        • Levy P.
        • Tamisier R.
        • Pépin J.L.
        Effects of 1-month withdrawal of ventilatory support in hypercapnic myotonic dystrophy type 1.
        Respirology. 2017; 22: 1416-1422